Caliper Shares Pull Back in Advance of Q2 Results | GenomeWeb
NEW YORK (GenomeWeb News) – Shares of Caliper Life Sciences closed down more than 12 percent in Monday trade on the Nasdaq in advance of the release of its second-quarter results on Wednesday.
 
As reported Friday by GenomeWeb Daily News, Caliper’s stock had gained around 53 percent in the month of July, after it had declined steadily through the first half of the year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.